Jonathan R. Rumble

Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products.

Jonathan R. Rumble, M. E. Cooper, Tina Soulis et al. · Journal of Clinical Investigation · 1997 · 191 citations · Full text

Accelerated Formation, Glycobiology, Experimental Diabetes +19

Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes

Richard E. Gilbert, Darren J. Kelly, Alison J. Cox et al. · Diabetologia · 2000 · 179 citations · Full text

Diabetic Retinopathy, Hypertension, Retina +11

Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis

G. Paizis, Richard E. Gilbert, Mark E. Cooper et al. · Journal of Hepatology · 2001 · 157 citations

Molecular Pharmacology, Receptor Blockade, Fibrosis +14

Endothelin Receptor Antagonism Ameliorates Mast Cell Infiltration, Vascular Hypertrophy, and Epidermal Growth Factor Expression in Experimental Diabetes

Richard E. Gilbert, Jonathan R. Rumble, Zemin Cao et al. · Circulation Research · 2000 · 79 citations · Full text

Diabetes-Associated Mesenteric Vascular Hypertrophy Is Attenuated by Angiotensin-Converting Enzyme Inhibition

Mark E. Cooper, Jonathan R. Rumble, Radko Komers et al. · Diabetes · 1994 · 78 citations

Hypertension, Ace Inhibition, Insulin Signaling +18